Corneal blindness is the fifth leading cause of blindness globally, particularly affecting the population in under-resourced countries. Trachoma and onchocerciasis represent the top causes of corneal blindness, but the incidence has significantly reduced in recent years following the successful implementation of various global health programs and initiatives. Infectious keratitis and pseudophakic bullous keratopathy remain a persistent burden in both developed and developing countries whereas xerophthalmia and ophthalmia neonatorum are the commonest causes of childhood corneal blindness. Given the immensity of the global burden secondary to corneal blindness, innovative and radical measures are urgently needed. In the past decade, cornea-related big data – enabled by the availability of corneal transplant registries, infectious keratitis studies, genomic studies, and gene banks – have improved the understanding and outcomes of many corneal diseases and facilitated more effective interventions and targeted public health resource planning. Moreover, digital innovations such as artificial intelligence and telemedicine have demonstrated their potential in improving the workflow efficiency in a real-world setting. In view of the recent advancements, this chapter aims to provide an overview of the global burden of corneal blindness and the potential roles of big data and digital innovations in transforming the clinical approach to corneal diseases in the future.